The document contains the morning exam session from April 2003 with multiple choice questions and answers regarding patent law and procedures. Question 1 discusses requirements for actual reduction to practice. Question 2 addresses consequences for failing to notify the office of a foreign filing after submitting a non-publication request. Question 3 regards providing a reply stating that required information is unknown or not readily available.
Patent bar practice questions april 2003Bradley Sands
The document contains a 15 question multiple choice exam from the USPTO regarding patent law procedures and rules. The questions cover topics such as proper Markush groups, responses to office actions, fees and deadlines, common ownership under 103, and when a final rejection is proper. The exam tests knowledge of the Manual of Patent Examining Procedure (MPEP).
This document provides guidance on drafting effective discovery in a dissolution case. It discusses the purpose and scope of discovery under Iowa rules, including relevant and privileged matters. Discovery objectives are outlined as capturing evidence, securing admissions, identifying witnesses, and preparing for trial. Advantages and disadvantages of written interrogatories are presented. Drafting considerations include instructions to parties, defining terms, tailoring requests, identifying persons and documents, and using contention interrogatories. The overall purpose is to educate parties on their discovery obligations and reduce surprises at trial.
The document summarizes remedies available in the Federal Court of Canada in 3 main sections:
1) Remedies providing immediate relief such as pre-trial injunctions and motions to strike claims.
2) Methods of disposition short of trial like default judgment, summary judgment, and summary trials.
3) Equitable and legal remedies available at or after trial including injunctions, damages, accounting of profits, and interest.
The document provides an overview and case study of ex parte reexamination. Key points:
1. Ex parte reexamination allows third parties to request review of a patent based on prior art. The request must show a substantial new question of patentability.
2. A case study examines two reexaminations of a catch basin filter patent. The second reexamination was more damaging despite relying on older prior art, due to additional evidence and amendments made during prosecution.
3. The case highlights how reexamination can strengthen a patent by confirming claims, but can also weaken a patent by adding limiting amendments or raising new validity issues, with implications for litigation such as intervening rights.
This document summarizes a webinar on addressing obviousness rejections under Section 103. It discusses the statutory requirements for obviousness, including the examiner's burden to establish a prima facie case of obviousness. It provides guidance on responding to obviousness rejections by challenging the teachings and combination of references. It also discusses supporting arguments with claim amendments and secondary considerations like commercial success. The webinar emphasizes engaging with examiners, who are not attorneys, and streamlining the prosecution process.
Merger Of Inter Partes Reexamination + Reissuekblaurence
The document summarizes considerations and procedures for merging, suspending, or allowing concurrent prosecution of inter partes reexamination and reissue proceedings. It discusses factors like the stage of each proceeding, whether merger would expedite matters, and issues unique to reissue. Generally the Office of Patent Legal Administration tries to merge or suspend proceedings to avoid inconsistent positions, but may allow concurrent prosecution to avoid delays from expunging records. The document analyzes several example cases where different approaches were taken.
The document contains the morning exam session from April 2003 with multiple choice questions and answers regarding patent law and procedures. Question 1 discusses requirements for actual reduction to practice. Question 2 addresses consequences for failing to notify the office of a foreign filing after submitting a non-publication request. Question 3 regards providing a reply stating that required information is unknown or not readily available.
Patent bar practice questions april 2003Bradley Sands
The document contains a 15 question multiple choice exam from the USPTO regarding patent law procedures and rules. The questions cover topics such as proper Markush groups, responses to office actions, fees and deadlines, common ownership under 103, and when a final rejection is proper. The exam tests knowledge of the Manual of Patent Examining Procedure (MPEP).
This document provides guidance on drafting effective discovery in a dissolution case. It discusses the purpose and scope of discovery under Iowa rules, including relevant and privileged matters. Discovery objectives are outlined as capturing evidence, securing admissions, identifying witnesses, and preparing for trial. Advantages and disadvantages of written interrogatories are presented. Drafting considerations include instructions to parties, defining terms, tailoring requests, identifying persons and documents, and using contention interrogatories. The overall purpose is to educate parties on their discovery obligations and reduce surprises at trial.
The document summarizes remedies available in the Federal Court of Canada in 3 main sections:
1) Remedies providing immediate relief such as pre-trial injunctions and motions to strike claims.
2) Methods of disposition short of trial like default judgment, summary judgment, and summary trials.
3) Equitable and legal remedies available at or after trial including injunctions, damages, accounting of profits, and interest.
The document provides an overview and case study of ex parte reexamination. Key points:
1. Ex parte reexamination allows third parties to request review of a patent based on prior art. The request must show a substantial new question of patentability.
2. A case study examines two reexaminations of a catch basin filter patent. The second reexamination was more damaging despite relying on older prior art, due to additional evidence and amendments made during prosecution.
3. The case highlights how reexamination can strengthen a patent by confirming claims, but can also weaken a patent by adding limiting amendments or raising new validity issues, with implications for litigation such as intervening rights.
This document summarizes a webinar on addressing obviousness rejections under Section 103. It discusses the statutory requirements for obviousness, including the examiner's burden to establish a prima facie case of obviousness. It provides guidance on responding to obviousness rejections by challenging the teachings and combination of references. It also discusses supporting arguments with claim amendments and secondary considerations like commercial success. The webinar emphasizes engaging with examiners, who are not attorneys, and streamlining the prosecution process.
Merger Of Inter Partes Reexamination + Reissuekblaurence
The document summarizes considerations and procedures for merging, suspending, or allowing concurrent prosecution of inter partes reexamination and reissue proceedings. It discusses factors like the stage of each proceeding, whether merger would expedite matters, and issues unique to reissue. Generally the Office of Patent Legal Administration tries to merge or suspend proceedings to avoid inconsistent positions, but may allow concurrent prosecution to avoid delays from expunging records. The document analyzes several example cases where different approaches were taken.
Attorney Mauricio Uribe, Michael Guiliana and Of Counsel Hironori Kubota present a Webinar focusing on strategic considerations for patent prosecution in the United States in view of the statutory requirements of Section 103. Leveraging years of focused prosecution practice, Knobbe Martens practitioners will provide insights related to the statutory requirements and best practices for effective prosecution.
The document discusses various third-party challenges to patents and patent applications that can be filed with the USPTO, including inter partes review (IPR), post grant review (PGR), covered business method patent review (CBM), preissuance submissions, and derivation proceedings. It provides details on the standards for instituting each proceeding, who can file, applicable grounds, timing requirements, procedures, and differences between the proceedings. USPTO fees for IPR are around $25k with typical total costs to completion of $350k-$700k. The overall success rate of IPRs is very high for petitioners, with around 85% of petitions granted and 60% of all claims found unpatent
Pros and Cons: PTAB vs. District CourtsPatexia Inc.
This document provides an overview of the pros and cons of challenging patent validity in the Patent Trial and Appeal Board (PTAB) versus district courts under the America Invents Act (AIA). It discusses the various post-grant review procedures available at the PTAB, including inter partes review, post-grant review, and covered business method patent review. Statistics on filing and outcome rates for AIA trials are presented. Factors to consider when deciding between the PTAB and district courts for a validity challenge are outlined, such as the nature of the decision maker, evidentiary standards, discovery opportunities, costs, and timing.
Partners Robb Roby and Mauricio Uribe provided an overview of Inter Partes Review (IPRs) procedures and strategies for challenging issued patents before the United States Patent and Trademark Office. They provided insights and practical tips related to understanding IPR practice in the United States and developing effective litigation strategies.
Speakers: Robb Roby, Mauricio Uribe
The presentation discusses different techniques for using US Patent and Trademark Office (USPTO) invalidity proceedings to invalidate issued patents. The presentation specifically discusses the new procedures available under the America Invents Act (AIA). Topics include Post-Grant Review (PGR) and Inter Partes Review (IPR) and cover business method review (CBM) programs. Deadlines as well as specific scheduling orders for these programs are discussed as well as how best to use the new programs at the USPTO.
This document provides an overview of pre-trial motions, including the pros and cons of filing pre-trial motions, options after a pre-trial motion is lost, the basics of filing motions, and types of common pre-trial motions such as motions to quash, motions to strike, demurrers, judgment on the pleadings, summary judgment motions, and motions in limine. It discusses the requirements and purpose of each type of motion, and provides concrete examples to illustrate how each motion may be used.
This document summarizes the key differences between the three main post-grant review procedures available at the USPTO: Inter Partes Review (IPR), Post-Grant Review (PGR), and Covered Business Method (CBM) review. It outlines who can file each type of petition, the applicable validity grounds and standards, estoppel effects, and timelines. The document also provides an overview of the IPR process, including strategies for petitioners and patent owners, and considerations regarding expert testimony, motions to stay litigation, and evaluating claims to challenge.
Inter Partes Review - Learning From the Denied PetitionsKlemchuk LLP
This document summarizes key considerations from inter partes review petitions that have been denied. It outlines the IPR process and requirements for petitions. It then analyzes examples of denied petitions, finding common reasons were failures to properly construe claims, support obviousness combinations, address patent owner responses, and provide sufficient expert testimony. It concludes with best practices such as avoiding time bars, strengthening expert opinions, considering claim construction, and thoroughly responding to petitions.
Knobbe Martens hosted a Pre-Conference Workshop on Monday, October 15, 2012, at the IN3 Medical Device Summit in San Francisco. Knobbe Partners Paul Conover, Curtis Huffmire, and Karen Vogel Weil presented a “Patent Update for Medical Device Companies.” This forum took place in the hub of device investment and innovation in the San Francisco Bay Area, and brought together a diverse group of medtech’s key thought leaders to candidly discuss the critical issues that will define the future of all players in the evolving device space.
The document provides updates from the USPTO on various topics. It discusses the authorization for internet communication form, an on-sale bar case under pre-AIA and AIA, the Marrakesh Treaty on copyright, and a new Post-Prosecution Pilot program. The Post-Prosecution Pilot allows applicants to request a conference with a panel of examiners to discuss an application after a final rejection but before filing an appeal. Requirements and timing for the pilot are outlined. The document also briefly mentions a new website called Examiner.ninja for researching patent examiners.
On March 30 and 31, 2017, Knobbe Martens attorneys presented written and oral educational material at an IP Seminar Series “Overseas Intellectual Property Rights Protection for Chinese Enterprises” sponsored by CHOFN, a Chinese IP law firm in Guangzhou and Shenzhen, China.
Litigating Disability Insurance Claims - Conference MaterialsRachel Hamilton
This document provides a summary of a presentation by Lee W. Marcus on innovative pretrial practices and procedures for litigating disability insurance claims. The presentation covered topics such as permissible venue in ERISA cases and concerns about forum shopping, when to file a motion to transfer venue, differences between ERISA and non-ERISA cases regarding venue and choice of law, reasons for removing ERISA cases to federal court, and advantages of filing motions under Rule 52 versus Rule 56.
This document provides information about various options for responding to a final rejection from the USPTO, including the After Final Consideration Pilot Program (AFCP), Pre-Appeal Brief Review, and the new Post-Prosecution Pilot (P3). The AFCP allows filing a response with a non-broadening amendment without an RCE fee. Pre-Appeal Brief Review involves filing a notice of appeal and brief for panel review. P3 allows filing arguments and an optional amendment for panel consideration without an RCE. The document compares the options and provides guidance on which to select based on the examiner's position and whether an appeal is ready to be filed.
Five major differences between IPRs and invalidation proceedingsAlexandraPuYang
Alexandra Yang of Fangda Partners examines the differences and similarities between IPRs in the U.S. and invalidation proceedings before the CNIPA to give U.S. practitioners and clients a clear picture of the patent invalidation proceedings in China.
Stays of Litigation Pending Post-AIA Patent ReviewKlemchuk LLP
Brief overview of post-AIA patent review procedures, overview of post-AIA stays of litigation pending patent review, and the analysis of district court orders on motions to stay pending patent review
MBHB-Webinar-PTAB-Williams-Lovsin-051616-FINALAndrew Williams
The document summarizes a webinar presentation about the first year of appellate review of decisions from the Patent Trial and Appeal Board (PTAB). Some key points include:
- The Federal Circuit has decided 93 cases from the PTAB so far, with 27 being precedential opinions. Most decisions have been affirmed or partially affirmed and partially reversed.
- The Supreme Court took up its first case involving the PTAB, In re Cuozzo Speed Technologies, which addressed the claim construction standard used in IPRs and the reviewability of institution decisions.
- Issues addressed in the webinar include claim construction, motions to amend claims, and the reviewability of PTAB institution decisions. Statistics on appeal outcomes are
Justice in time: applying TOC to the low courts system in Israel. Shimeon PasscommonsenseLT
This document summarizes a presentation about applying Theory of Constraints (TOC) concepts to manage the court system in Israel more effectively. It describes some of the challenges faced, such as increasing workload and long lead times. It then outlines 6 steps to apply TOC: 1) Define the goal as providing timely justice. 2) Measure throughput, costs, inventory and lead times. 3) Identify judges as the constraint. 4) Exploit the constraint through alternative dispute resolution and reducing ineffective time. 5) Subordinate other parts of the system to the constraint. 6) Elevate the constraint by working to increase the number of judges. Examples are given of how techniques like strategic gating, drum-buffer-rope
Attorney Mauricio Uribe, Michael Guiliana and Of Counsel Hironori Kubota present a Webinar focusing on strategic considerations for patent prosecution in the United States in view of the statutory requirements of Section 103. Leveraging years of focused prosecution practice, Knobbe Martens practitioners will provide insights related to the statutory requirements and best practices for effective prosecution.
The document discusses various third-party challenges to patents and patent applications that can be filed with the USPTO, including inter partes review (IPR), post grant review (PGR), covered business method patent review (CBM), preissuance submissions, and derivation proceedings. It provides details on the standards for instituting each proceeding, who can file, applicable grounds, timing requirements, procedures, and differences between the proceedings. USPTO fees for IPR are around $25k with typical total costs to completion of $350k-$700k. The overall success rate of IPRs is very high for petitioners, with around 85% of petitions granted and 60% of all claims found unpatent
Pros and Cons: PTAB vs. District CourtsPatexia Inc.
This document provides an overview of the pros and cons of challenging patent validity in the Patent Trial and Appeal Board (PTAB) versus district courts under the America Invents Act (AIA). It discusses the various post-grant review procedures available at the PTAB, including inter partes review, post-grant review, and covered business method patent review. Statistics on filing and outcome rates for AIA trials are presented. Factors to consider when deciding between the PTAB and district courts for a validity challenge are outlined, such as the nature of the decision maker, evidentiary standards, discovery opportunities, costs, and timing.
Partners Robb Roby and Mauricio Uribe provided an overview of Inter Partes Review (IPRs) procedures and strategies for challenging issued patents before the United States Patent and Trademark Office. They provided insights and practical tips related to understanding IPR practice in the United States and developing effective litigation strategies.
Speakers: Robb Roby, Mauricio Uribe
The presentation discusses different techniques for using US Patent and Trademark Office (USPTO) invalidity proceedings to invalidate issued patents. The presentation specifically discusses the new procedures available under the America Invents Act (AIA). Topics include Post-Grant Review (PGR) and Inter Partes Review (IPR) and cover business method review (CBM) programs. Deadlines as well as specific scheduling orders for these programs are discussed as well as how best to use the new programs at the USPTO.
This document provides an overview of pre-trial motions, including the pros and cons of filing pre-trial motions, options after a pre-trial motion is lost, the basics of filing motions, and types of common pre-trial motions such as motions to quash, motions to strike, demurrers, judgment on the pleadings, summary judgment motions, and motions in limine. It discusses the requirements and purpose of each type of motion, and provides concrete examples to illustrate how each motion may be used.
This document summarizes the key differences between the three main post-grant review procedures available at the USPTO: Inter Partes Review (IPR), Post-Grant Review (PGR), and Covered Business Method (CBM) review. It outlines who can file each type of petition, the applicable validity grounds and standards, estoppel effects, and timelines. The document also provides an overview of the IPR process, including strategies for petitioners and patent owners, and considerations regarding expert testimony, motions to stay litigation, and evaluating claims to challenge.
Inter Partes Review - Learning From the Denied PetitionsKlemchuk LLP
This document summarizes key considerations from inter partes review petitions that have been denied. It outlines the IPR process and requirements for petitions. It then analyzes examples of denied petitions, finding common reasons were failures to properly construe claims, support obviousness combinations, address patent owner responses, and provide sufficient expert testimony. It concludes with best practices such as avoiding time bars, strengthening expert opinions, considering claim construction, and thoroughly responding to petitions.
Knobbe Martens hosted a Pre-Conference Workshop on Monday, October 15, 2012, at the IN3 Medical Device Summit in San Francisco. Knobbe Partners Paul Conover, Curtis Huffmire, and Karen Vogel Weil presented a “Patent Update for Medical Device Companies.” This forum took place in the hub of device investment and innovation in the San Francisco Bay Area, and brought together a diverse group of medtech’s key thought leaders to candidly discuss the critical issues that will define the future of all players in the evolving device space.
The document provides updates from the USPTO on various topics. It discusses the authorization for internet communication form, an on-sale bar case under pre-AIA and AIA, the Marrakesh Treaty on copyright, and a new Post-Prosecution Pilot program. The Post-Prosecution Pilot allows applicants to request a conference with a panel of examiners to discuss an application after a final rejection but before filing an appeal. Requirements and timing for the pilot are outlined. The document also briefly mentions a new website called Examiner.ninja for researching patent examiners.
On March 30 and 31, 2017, Knobbe Martens attorneys presented written and oral educational material at an IP Seminar Series “Overseas Intellectual Property Rights Protection for Chinese Enterprises” sponsored by CHOFN, a Chinese IP law firm in Guangzhou and Shenzhen, China.
Litigating Disability Insurance Claims - Conference MaterialsRachel Hamilton
This document provides a summary of a presentation by Lee W. Marcus on innovative pretrial practices and procedures for litigating disability insurance claims. The presentation covered topics such as permissible venue in ERISA cases and concerns about forum shopping, when to file a motion to transfer venue, differences between ERISA and non-ERISA cases regarding venue and choice of law, reasons for removing ERISA cases to federal court, and advantages of filing motions under Rule 52 versus Rule 56.
This document provides information about various options for responding to a final rejection from the USPTO, including the After Final Consideration Pilot Program (AFCP), Pre-Appeal Brief Review, and the new Post-Prosecution Pilot (P3). The AFCP allows filing a response with a non-broadening amendment without an RCE fee. Pre-Appeal Brief Review involves filing a notice of appeal and brief for panel review. P3 allows filing arguments and an optional amendment for panel consideration without an RCE. The document compares the options and provides guidance on which to select based on the examiner's position and whether an appeal is ready to be filed.
Five major differences between IPRs and invalidation proceedingsAlexandraPuYang
Alexandra Yang of Fangda Partners examines the differences and similarities between IPRs in the U.S. and invalidation proceedings before the CNIPA to give U.S. practitioners and clients a clear picture of the patent invalidation proceedings in China.
Stays of Litigation Pending Post-AIA Patent ReviewKlemchuk LLP
Brief overview of post-AIA patent review procedures, overview of post-AIA stays of litigation pending patent review, and the analysis of district court orders on motions to stay pending patent review
MBHB-Webinar-PTAB-Williams-Lovsin-051616-FINALAndrew Williams
The document summarizes a webinar presentation about the first year of appellate review of decisions from the Patent Trial and Appeal Board (PTAB). Some key points include:
- The Federal Circuit has decided 93 cases from the PTAB so far, with 27 being precedential opinions. Most decisions have been affirmed or partially affirmed and partially reversed.
- The Supreme Court took up its first case involving the PTAB, In re Cuozzo Speed Technologies, which addressed the claim construction standard used in IPRs and the reviewability of institution decisions.
- Issues addressed in the webinar include claim construction, motions to amend claims, and the reviewability of PTAB institution decisions. Statistics on appeal outcomes are
Justice in time: applying TOC to the low courts system in Israel. Shimeon PasscommonsenseLT
This document summarizes a presentation about applying Theory of Constraints (TOC) concepts to manage the court system in Israel more effectively. It describes some of the challenges faced, such as increasing workload and long lead times. It then outlines 6 steps to apply TOC: 1) Define the goal as providing timely justice. 2) Measure throughput, costs, inventory and lead times. 3) Identify judges as the constraint. 4) Exploit the constraint through alternative dispute resolution and reducing ineffective time. 5) Subordinate other parts of the system to the constraint. 6) Elevate the constraint by working to increase the number of judges. Examples are given of how techniques like strategic gating, drum-buffer-rope
Patent Litigation Issues and the America Invents Act
Trial Practice Before the Patent Trial and Appeal Board
1. Trial practice before the PTAB in contested
proceedings
INTELLECTUAL PROPERTY LAW SECTION Marc A . Hubbard
DALLAS BAR ASSOCIATION HUBBARD LAW, PLLC
October 18, 2012
Dallas, Texas
Hubbard ip
6. Topics
• Overview of timing of basic trial procedures in context of reviews
• Overview of motion practice, evidence and discovery
• Discussion of some key issues
6
Hubbard ip
7. Rules governing trial procedures at PTAB
• Part 42, Subpart A, of 37 C.F.R. governs trial in four types of contested proceedings:
• Inter partes review (IPR)
• Post grant review (PGR)
• Transitional covered business method patent review (CBMR)
• Derivation proceeding
• Detailed guidance: Office Patent Trial Practice Guide
7
Hubbard ip
8. Petition Filed
Optional PO
3 months PTAB Contested
response
< 3 months
Proceeding
Overview
Decision on
authorization
No
Rehearing
Yes
Decision on
rehearing
No No appeal /
Trial <12 months, unless
Try again
extended by 6 months
Yes
Trial
Yes
Settlement Dismissal*
No *Unless board
has already
Final decision
made a decision
Motion for
rehearing /
Appeal to Fed.
Cir.
8
Hubbard ip
9. Petition
• Standing
• Must certify that patent/application available for review and demonstrate that statutory requirements for bringing
proceeding have met
• Must certify that petitioner is not barred or estopped
• Mandatory notices (Real party in interest, related matters, lead and backup counsel, service information)
• Challenge to one or more claims
• Evidence
• All evidence relied upon must be filed with petition (subject to limited opportunities to supplement)
• Filing fee
• Must accompany petition; non-refundable
9
Hubbard ip
10. Challenge
• For each challenged claim
• Proposed claim construction
• Can be sufficient to state simply “broadest reasonable interpretation, as understood by one of ordinary skill
in the art and consistent with the disclosure”
• Board will apply the broadest reasonably interpretation standard
• If specific term should have a meaning other than a plain meaning, must identify support in disclosure for it
• Specific statutory grounds (§102, §103 for IPR, PGR and CBM; §§101 and112 for PGR and CBMR)
• How claim is unpatentable
• Must specify exhibit # and specific portions of evidence to support challenge
• Claim charts recommended, but count toward page limits (unless attached as evidence from other case)
10
Hubbard ip
11. Patent owner’s preliminary response
• Optional
• Evidence can be attached, but no testimony can be taken prior to authorization of
trial
• May disclaim one or more claims
• May waive response early in time period in order to expedite decision by Board on
whether to authorize trial
11
Hubbard ip
12. Types of responses for a patent owner to consider
• The petitioner is statutorily barred
• The references are not in fact prior art
• The prior art lacks a material limitation found in all of the independent claims
• The prior art teaches or suggests away from a combination
• The claim interpretation is unreasonable
• For post-grant review raising §101 grounds, a brief explanation as to how the
challenged claims are directed to a patent-eligible invention
12
Hubbard ip
13. Institution of trial
• For IPR
• Petition must demonstrate a reasonable likelihood that petition would prevail as to
at least one of the challenged claims
• Viewed by PTAB as giving it more discretion (can be 50/50)
• For PGR/CBMR
• Petition must demonstrate that it is more likely than not that at least one
challenged claim is unpatentable
• Board will identify claims and specific grounds on which trial is being authorized
13
Hubbard ip
14. Trial management
• Board has broad discretion manage the proceeding as it sees fit, but within confines
of statutory requirements
• Scheduling order (see model in Trial Guide) sets up stages
• All relief must be sought through petition or motion
• Motions may only be entered with Board approval
14
Hubbard ip
15. Due Dates Set By Scheduling Order
(Parties may stipulate to different dates for 1 to 5)
Standard 0
Board decides to institute trial and
issues scheduling order
Schedule for Initial conference call
PO
Discovery
Period
IPR/PGR/ (1) 3 months
PO: (1) response to petition; (2)
motion to amend claims
CBMR Petitioner
Discovery
Period
Petitioner: (1) reply to PO response
(2) 6 months and (2) opposition to motion to
amend PO
Discovery
Period
PO: reply to opposition to
(3) 7 months
amendment
Pet: motion for observations on
(4) 7 months + 3 weeks cross-x of reply witnesses
PO/Pet: motion to exclude
evidence / req. hearing
Pet/PO: Opposition to motion to
(5) 8 months + 1 week exclude
PO: response to observations
(6) 8 months + 2 weeks Replies to motions to exclude
Oral Hearing (only upon request)
12 months Final Decision
15
Hubbard ip
16. Patent owner’s response to petition
• Identify all involved claims that are believed to be patentable
• State basis for that belief
• Include any affidavits and other additional factual evidence to be relied upon
• Explain relevance of the evidence
• May include claim charts
16
Hubbard ip
17. Motion practice
• No motion will not be entered without prior Board authorization, except —
• if impractical to seek prior Board authorization (e.g. motions to seal and motions filed with
petition)
• motions for which authorization is automatically granted by rules or in scheduling order (e.g.
requests for rehearing, observations on cross-examination, and motions to exclude evidence)
• Generally, however, time limits are imposed for making these motions
• Authorization for all other motions obtained during initial conference call or subsequent call.
• Initial conference about one month from the date of institution to discuss the motions that the
parties intend to file and to determine if any adjustment needs to be made to the Scheduling Order
• Procedural issues likely to be decided during conference calls to avoid need for additional briefing
17
Hubbard ip
18. Motions to amend claims
• Only one motion to amend as of right (statutory)
• Timing
• Although permission to file is not required, patent owners expected to confer with
Board before making it (preferably during initial conference call) as it may impact
schedule
• Motion expected to be presented with patent owner’s response
• Good cause required for motions to amend sought later in proceeding
(amendment to advance settlement usually good enough)
18
Hubbard ip
19. Nature of amendment limited
• Generally, one substitute claim per challenged claim, unless need for more than one
demonstrated
• Motion must identify support for each claim that is added or amended
• Motion can be denied if —
• Amendment does not respond to a ground of unpatentability involved in the trial
• Enlarges the scope of the claim or introduces new subject matter
• Petitioner may respond with additional evidence that addresses new issues
• Amendments are subject to §252 intervening rights
19
Hubbard ip
20. Evidence
• Admissibility of evidence generally governed by Federal Rules of Evidence
• Testimony
• Uncompelled direct testimony by affidavits
• All other (compelled direct, cross-examination, redirect) by deposition
• Objections must be made to preserve right to move to exclude evidence
• To deposition evidence: at time of deposition
• 10 business days of institution of trial for evidence filed with Petition; otherwise 5 days of service
• May respond to objection by serving supplemental evidence within 10 business days
20
Hubbard ip
21. Discovery
• Discovery not permitted except —
• For “routine discovery”
• On agreed upon mandatory initial disclosures, if agreed to by the parties prior to patent
owner’s preliminary response
• On motion
• May ask for any type of discover permitted by FRCP
• As otherwise agreed by the parties
• Board expects to enter standard E-discovery order modeled after the Federal Circuit’s model
order when party seeks ESI beyond routine discovery
21
Hubbard ip
22. Routine discovery
• Cross-examination of affidavit testimony within time period authorized by Board in
scheduling order
• Any exhibit cited in paper or in testimony must be served with paper or testimony, unless
previously served or otherwise agreed by parties
• Mandatory disclosure of relevant information inconsistent with position advanced by
party
• Must be served prior to or with paper containing inconsistent statement
• Does not apply to privileged documents
• This apparent duty extends to inventors, corporate officers and persons involved with
preparation of documents
22
Hubbard ip
23. Agreed upon “mandatory initial disclosures”
• Parties may agree to mandatory discovery in the form of initial disclosures
• To be done not later than filing of patent owner preliminary statement or time for filing the
statement
• Upon institution of trial, parties may automatically take discovery of information identified in
the initial disclosure
• Two options
• (1) FRCP Rule 26(a)(1)(A)
• (2) Much more extensive list of disclosures set out in the Trial Guide
• Initial disclosures must be filed as exhibits
23
Hubbard ip
24. Discovery upon motion
• Any types of discovery available under the Federal Rules of Civil Procedure can be
sought, but motion must be filed
• Grant of motion requires showing of —
• “interests of justice” for IPR and derivations (high threshold)
• “good cause” for in PGR and CBM (lower threshold)
• Example of when it might be sought:
• when a party raises an issue, where the evidence on that issue is uniquely in the
possession of the party that raised it
24
Hubbard ip
25. Supplemental information
• Within 1 month of institution of trial—parties may move to submit supplemental
information relevant to a claim that is subject of trial
• Otherwise, party must request authorization to file a motion to submit the
information; motion must show —
• why the supplemental information reasonably could not have been obtained earlier
• that consideration of the supplemental information would be in the interests-of-
justice (a relatively high standard)
25
Hubbard ip
26. Confidentiality / protective orders
• Petition may be filed with motion to seal (with proposed protective order: either its own or PTO
default protective order)
• PO cannot see confidential information unless agrees to protective order supplied by
Petitioner, or parties agree on one
• If not order agreed to prior to institution of trial, Board will enter default standard protective
order
• Confidential information that is subject to a protective order will become public 45 days after
denial of a petition or 45 days after final judgment
• Party may file a motion to expunge the information from the record prior to the information
becoming public
• Redaction preferred over sealing of document
26
Hubbard ip
27. Fees / Page limits on petitions
• Filing fees
• IPR: $27,200 + $600 per excess claim (over 20)
• PGR/CBM: $35,800 + $800 per excess claim
• Page limits: Petitions for IPR and Derivation limited to 60 pages; 80 pages for PGR/CBM (double-spacing; 14 point font;
excludes exhibits)
• Claim charts can be single spaced
• Use claim charts from other proceedings as exhibits
• Omit extensive discussions of basic legal principles
• Break down claims and file multiple petitions
• Board might decline to institute proceeding if too many claims or too many references on grounds that it cannot be
completed within 1 year
27
Hubbard ip
28. Miscellaneous
• Counsel requirements
• Must specify lead and back up counsel
• Non-registered attorneys may apply for pro hac vice admission, but Board will
condition admission on having lead counsel be registered with PTO
• Patent owner estoppel: PO may not take action inconsistent with an adverse
judgment by obtaining patent:
• with patentably indistinct claims
• with an amendment to specification or drawing denied during trial
28
Hubbard ip
29. Conclusion
• No trials have yet been authorized, so we don’t yet have anything to judge how well
these will work
• Rules are geared toward keeping a tight control over the parties and to prevent
abuses
• PTO is serious about its 1 year mandate
• Board seems to be very open and encourages interaction with it
29
Hubbard ip